BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$415M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$247M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$186M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$179M |
| 5 |
Advanced Micro Devices
AMD
|
+$117M |
Top Sells
| 1 |
Apple
AAPL
|
+$547M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 3 |
Microsoft
MSFT
|
+$479M |
| 4 |
Amazon
AMZN
|
+$316M |
| 5 |
Diageo
DEO
|
+$288M |
Sector Composition
| 1 | Technology | 16.61% |
| 2 | Financials | 9.93% |
| 3 | Healthcare | 9.28% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Five Below
FIVE
$8.05B
| $3.69M | 0.01% |
26,806
+23,139
| +631% | +$3.19M |
|
927
BP
BP
$88.8B
| $3.69M | 0.01% |
129,239
+64,229
| +99% | +$1.83M |
|
928
First Citizens BancShares
FCNCA
$25.4B
| $3.69M | 0.01% |
4,625
-747
| -14% | -$596K |
|
929
Golar LNG
GLNG
$4.27B
| $3.68M | 0.01% |
147,723
+94,295
| +176% | +$2.35M |
|
930
SAP
SAP
$301B
| $3.68M | 0.01% |
45,276
-28,856
| -39% | -$2.34M |
|
931
Amicus Therapeutics
FOLD
$2.45B
| $3.67M | 0.01% |
351,746
+8,094
| +2% | +$84.5K |
|
932
SPDR S&P Insurance ETF
KIE
$830M
| $3.65M | 0.01% |
100,900
-203,900
| -67% | -$7.38M |
|
933
Catalyst Pharmaceutical
CPRX
$2.42B
| $3.62M | 0.01% |
282,017
+251,191
| +815% | +$3.22M |
|
934
United Therapeutics
UTHR
$18.3B
| $3.62M | 0.01% |
17,266
+1,116
| +7% | +$234K |
|
935
AutoNation
AN
$8.42B
| $3.61M | 0.01% |
35,472
-14,978
| -30% | -$1.53M |
|
936
Ormat Technologies
ORA
$5.56B
| $3.61M | 0.01% |
41,883
+23,590
| +129% | +$2.03M |
|
937
Eagle Materials
EXP
$7.49B
| $3.6M | 0.01% |
33,582
+7,120
| +27% | +$763K |
|
938
Coupang
CPNG
$59.2B
| $3.59M | 0.01% |
+215,654
| New | +$3.59M |
|
939
Riot Platforms
RIOT
$5.78B
| $3.58M | 0.01% |
511,281
+483,892
| +1,767% | +$3.39M |
|
940
Marten Transport
MRTN
$949M
| $3.58M | 0.01% |
187,039
+7,524
| +4% | +$144K |
|
941
Arcus Biosciences
RCUS
$1.22B
| $3.58M | 0.01% |
136,957
+73,204
| +115% | +$1.92M |
|
942
ASE Group
ASX
$24.2B
| $3.58M | 0.01% |
717,697
-679,357
| -49% | -$3.39M |
|
943
iShares MSCI Canada ETF
EWC
$3.28B
| $3.56M | 0.01% |
115,841
| – | – |
|
944
BRF SA
BRFS
$5.99B
| $3.56M | 0.01% |
1,520,798
+324,993
| +27% | +$760K |
|
945
SEI Investments
SEIC
$10.7B
| $3.56M | 0.01% |
72,536
-3,791
| -5% | -$186K |
|
946
WD-40
WDFC
$2.85B
| $3.55M | 0.01% |
20,179
+15,202
| +305% | +$2.67M |
|
947
ManpowerGroup
MAN
$1.83B
| $3.53M | 0.01% |
54,518
-74,190
| -58% | -$4.8M |
|
948
e.l.f. Beauty
ELF
$7.83B
| $3.52M | 0.01% |
93,657
+80,359
| +604% | +$3.02M |
|
949
Mohawk Industries
MHK
$8.68B
| $3.51M | 0.01% |
38,492
-73,126
| -66% | -$6.67M |
|
950
PTC Therapeutics
PTCT
$4.84B
| $3.51M | 0.01% |
69,922
+36,354
| +108% | +$1.82M |
|